Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-281. Status: posted.
Live Procurement Feed
Showing 1201–1240 of 1445 open tenders across CanadaBuys, SAM.gov, Grants.gov, and UK Contracts Finder.
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-281. Status: posted.
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-282. Status: posted.
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-291. Status…
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) — Agency: HHS-NIH11. Opportunity #PAR-25-148. Status: posted.
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-286. Status: posted.
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-287. Status: posted.
NICHD Small Research Grant Program (R03 Clinical Trial Required) — Agency: HHS-NIH11. Opportunity #PA-25-125. Status: posted.
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-243. Status: posted.
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-105. Status: posted.
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-273. Status: posted.
Focused Technology Research and Development (R01 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-203. Status: posted.
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-027. Status: posted.
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PA-25-172. Status: posted.
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) — Agency: HHS-NIH11. Opportunity #PAR-25-136. Status: posted.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-145. Status: posted.
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-24-311. Status: posted.
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-175. Status: posted.
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-227. Status: posted.
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) — Agency: HHS-NIH11. Opportunity #PAR-25-207. Status: posted.
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-143. Status: posted.
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-185. Status: posted.
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-233. Status: posted.
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-144. Status: posted.
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-024. Status: posted.
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PA-25-093. Status: posted.
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-043. Status: posted.
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-044. Status: posted.
Laboratory Flexible Funding Model (LFFM) — Agency: HHS-FDA. Opportunity #RFA-FD-25-007. Status: posted.
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) — Agency: HHS-NIH11. Opportunity #PAR-25-383. Status: posted.
Qualification: A Notice will be posted continuously until 31 January 2028, 2:00pm EST on the Government Electronic Tendering Service (GETS) to allow new Suppliers to become qualified. Existing qualified Suppliers, who ha…
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) — Agency: HHS-FDA. Opportunity #RFA-FD-25-017. Status: posted.
1. Background The Department of National Defence (DND) moves materiel and personnel domestically and internationally on an as required basis to support operations. DND accomplishes this task primarily through its own mea…
1. Background The Department of National Defence (DND) moves materiel domestically and internationally on an as required basis to support operations and exercises. DND accomplishes this task primarily through its own mea…
Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-437. Status: posted.
AMENDMENT TO CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time and Canada Buys posting closing time. All required supporting documentation and bid submission must be submitted by M…
AMENDMENT TO CLOSING TIME: Please disregard the Ariba Discovery posting response deadline closing time and Buyandsell posting closing time. All required supporting documentation and bid submission must be submitted on 31…
This is amendment #009 (June 2026) to the Request for Supply arrangement for Temporary Help Services for the National Capital Region. Suppliers are reminded of the importance of reading this document in its entirety, as …
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) — Agency: HHS-NIH11. Opportunity #PA-25-168. Status: posted.
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) — Agency: HHS-NIH11. Opportunity #PAR-25-333. Status: posted.
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) — Agency: HHS-NIH11. Opportunity #PA-25-424. Status: posted.